Patient Reported Outcomes with UVA-1 Therapy for Treatment of Sclerosing Skin Diseases

NAEnrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Scleroderma, SystemicMorpheaGraft Vs Host Disease

Interventions

DEVICE

UVA-1 Phototherapy

All patients will receive UVA-1 Phototherapy treatments

Trial Locations (1)

University of Utah Dermatology, Murray

All Listed Sponsors

lead

University of Utah

OTHER